Topical application of gemcitabine generates microvesicle particles in human and murine skin.
- Published in:
- Biofactors, 2022, v. 48, n. 6, p. 1295, doi. 10.1002/biof.1924
- By:
- Publication type:
- Article
Works matching IS 09516433 AND DT 2022 AND VI 48 AND IP 6
Results: 12
1
2
Platelet Activating Factor (PAF): A Mediator of Inflammation.
- Published in:
- Biofactors, 2022, v. 48, n. 6, p. 1189, doi. 10.1002/biof.1883
- By:
- Publication type:
- Article
3
Plasmalogens and platelet‐activating factor roles in chronic inflammatory diseases.
- Published in:
- Biofactors, 2022, v. 48, n. 6, p. 1203, doi. 10.1002/biof.1916
- By:
- Publication type:
- Article
4
Platelet activating factor: Have we been missing the forest for the trees?
- Published in:
- Biofactors, 2022, v. 48, n. 6, p. 1184, doi. 10.1002/biof.1908
- By:
- Publication type:
- Article
5
Oxidized phospholipids and lipoprotein‐associated phospholipase A<sub>2</sub> (Lp‐PLA<sub>2</sub>) in atherosclerotic cardiovascular disease: An update.
- Published in:
- Biofactors, 2022, v. 48, n. 6, p. 1257, doi. 10.1002/biof.1890
- By:
- Publication type:
- Article
6
The role of PAF in immunopathology: From immediate hypersensitivity reactions to fungal defense.
- Published in:
- Biofactors, 2022, v. 48, n. 6, p. 1217, doi. 10.1002/biof.1888
- By:
- Publication type:
- Article
7
Platelet‐activating factor and microvesicle particles as potential mediators for the toxicity associated with intoxicated thermal burn injury.
- Published in:
- Biofactors, 2022, v. 48, n. 6, p. 1250, doi. 10.1002/biof.1917
- By:
- Publication type:
- Article
8
New transcriptome and clinical findings of platelet‐activating factor in chronic spontaneous urticaria: Pathogenic and treatment relevance.
- Published in:
- Biofactors, 2022, v. 48, n. 6, p. 1284, doi. 10.1002/biof.1880
- By:
- Publication type:
- Article
9
Is there an interplay between the SARS‐CoV‐2 spike protein and Platelet‐Activating factor?
- Published in:
- Biofactors, 2022, v. 48, n. 6, p. 1271, doi. 10.1002/biof.1877
- By:
- Publication type:
- Article
10
PAF‐induced inflammatory and immuno‐allergic ophthalmic diseases and their mitigation with PAF receptor antagonists: Cell and nuclear effects.
- Published in:
- Biofactors, 2022, v. 48, n. 6, p. 1226, doi. 10.1002/biof.1848
- By:
- Publication type:
- Article
11
Issue Information ‐ Cover.
- Published in:
- Biofactors, 2022, v. 48, n. 6, p. 1, doi. 10.1002/biof.1753
- Publication type:
- Article
12
Issue Information.
- Published in:
- Biofactors, 2022, v. 48, n. 6, p. 1179, doi. 10.1002/biof.1751
- Publication type:
- Article